MSGR Holdings
Direxion mRNA ETF
1W: +0.0%
1M: +4.3%
3M: -10.7%
1Y: -0.9%
$13.91
Last traded 2023-05-02 — delisted
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM—
Holdings23
Top 10 Wt64.2%
Beta—
% Profitable17%
Coverage100%
Portfolio Valuation
P/E44.6
P/B5.6
P/S8.9
EV/EBITDA24.0
P/FCF45.9
PEG4.43
Profitability & Returns
Gross Margin75.6%
Net Margin2.3%
ROE1.5%
ROA1.0%
ROIC6.6%
Div Yield—%
Leverage & Liquidity
Debt/Equity0.18
Debt/Assets0.12
Net Debt/EBITDA-2.2x
Interest Cov3.8x
Current Ratio3.71
Quick Ratio3.42
Growth (YoY)
Revenue+12.3%
Net Income+7.2%
EPS+7.2%
FCF+27.2%
EBITDA+24.8%
Rev CAGR 3Y+8.7%
Quality Scores
Piotroski F3.9
Altman Z2.26
IS Quality49.0
IS Overall36.7
IS Value38.1
Median P/E-3.7
Sector Breakdown
1 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 23 | 99.9% | -8.0 |
Smart Money Overlap
0 holdings with signalsNo holdings with active convergence signals
Showing 23 of 23 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | VRTX | 8.09% | $253,116 | 769 | 29.1 | $128.1B | Healthcare |
| 2 | BeiGene Ltd | BGNE | 7.51% | $235,008 | 910 | 3.6 | $20.2B | Healthcare |
| 3 | Arcturus Therapeutics Holdings Inc | ARCT | 7.45% | $233,017 | 8,672 | -3.9 | $370M | Healthcare |
| 4 | SCLX | SCLX | 6.81% | $213,206 | 17,433 | -0.1 | $34M | Healthcare |
| 5 | Alnylam Pharmaceuticals Inc | ALNY | 6.44% | $201,643 | 994 | 36.0 | $29.4B | Healthcare |
| 6 | PTC THERAPEUTICS INC USD 0.001 | PTCT | 6.31% | $197,429 | 3,669 | -129.5 | $5.3B | Healthcare |
| 7 | BIONTECH SE | BNTX | 5.76% | $180,201 | 1,490 | -12.7 | $24.3B | Healthcare |
| 8 | Moderna Inc | MRNA | 5.59% | $175,014 | 1,240 | -23.8 | $75.4B | Healthcare |
| 9 | SAREPTA THERAPEUTICS INC | SRPT | 5.30% | $165,793 | 1,313 | -12.2 | $1.8B | Healthcare |
| 10 | Maravai LifeSciences Holdings Inc | MRVI | 4.93% | $154,254 | 10,940 | -14.8 | $2.2B | Healthcare |
| 11 | Intellia Therapeutics Inc | NTLA | 4.33% | $135,423 | 3,787 | -3.6 | $1.7B | Healthcare |
| 12 | IONIS PHARMACEUTICALS INC | IONS | 4.10% | $128,189 | 3,548 | -12.6 | $7.2B | Healthcare |
| 13 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 3.68% | $115,072 | 3,846 | -28.7 | $9.0B | Healthcare |
| 14 | AVIDITY BIOSCIENCES INC | RNA | 3.67% | $114,739 | 7,285 | -2.0 | $134M | Healthcare |
| 15 | CureVac NV | CVAC | 3.38% | $105,800 | 13,325 | 4.4 | $1.0B | Healthcare |
| 16 | DYNE THERAPEUTICS INC | DYN | 3.05% | $95,319 | 9,078 | -4.6 | $2.8B | Healthcare |
| 17 | ARBUTUS BIOPHARMA CORP NPV | ABUS | 3.00% | $93,811 | 31,693 | 5.6 | $879M | Healthcare |
| 18 | Sangamo Therapeutics Inc | SGMO | 2.26% | $70,801 | 43,436 | -0.2 | $31M | Healthcare |
| 19 | Stoke Therapeutics Inc | STOK | 1.94% | $60,855 | 7,151 | -7.6 | $1.7B | Healthcare |
| 20 | Gritstone Oncology Inc | GRTS | 1.94% | $60,724 | 23,628 | -0.0 | $4M | Healthcare |
| 21 | HLVX | HLVX | 1.57% | $49,211 | 3,548 | -0.7 | $105M | Healthcare |
| 22 | PROQR THERAPEUTICS NV | PRQR | 1.54% | $48,130 | 21,680 | -3.7 | $172M | Healthcare |
| 23 | PEPGEN INC | PEPG | 1.29% | $40,481 | 3,223 | -1.5 | $158M | Healthcare |